Article Versions Notes

He Z, Chen Y, Xia B, Cheng Z, Zhao P, Qi Z, Zhu Y. CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. Pharmaceutics. 2025; 17(12):1524. https://doi.org/10.3390/pharmaceutics17121524

He, Zhiwei, Yibo Chen, Binghui Xia, Zimeng Cheng, Ping Zhao, Zhongtian Qi, and Yongzhe Zhu. 2025. "CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein" Pharmaceutics 17, no. 12: 1524. https://doi.org/10.3390/pharmaceutics17121524

He, Z., Chen, Y., Xia, B., Cheng, Z., Zhao, P., Qi, Z., & Zhu, Y. (2025). CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. Pharmaceutics, 17(12), 1524. https://doi.org/10.3390/pharmaceutics17121524